Influence of cyclooxygenase and thromboxane synthetase inhibitors upon amphetamine and caffeine action at the level of central nervous system (CNS)
D000662:Amphetamines / Q000494:pharmacology*; D000818:Animals; D002110:Caffeine / Q000494:pharmacology*; D002490:Central Nervous System / Q000187:drug effects* / Q000378:metabolism; D016861:Cyclooxygenase Inhibitors; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D007093:Imidazoles / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D051379:Mice; D010088:Oxidoreductases / Q000037:antagonists & inhibitors*; D011453:Prostaglandins / Q000378:metabolism; D011597:Psychomotor Performance / Q000187:drug effects; D012980:Sodium Salicylate / Q000494:pharmacology; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*; D013931:Thromboxanes / Q000378:metabolism
D000662:Amphetamines; D016861:Cyclooxygenase Inhibitors; D004791:Enzyme Inhibitors; D007093:Imidazoles; D011453:Prostaglandins; D013931:Thromboxanes; D002110:Caffeine; D010088:Oxidoreductases; D013930:Thromboxane-A Synthase; D012980:Sodium Salicylate; D007213:Indomethacin